Your Step Counter May Do More Than Track Movement—It Could Keep Diabetes In Check

Key takeaways

Garmin Health used its summit in Bangkok to promote wrist devices as clinical tools for diabetes and metabolic health, while announcing record 2025 revenue of US$7.25 billion and raising its 2026 target to US$8.15 billion.

• Garmin highlighted wrist wearables as clinical tools for type 2 diabetes and metabolic health.
• The company reported record full‑year revenue of US$7.25 billion for 2025.
• It raised its 2026 revenue target to approximately US$8.15 billion.

Summarised automatically by AI from the original article by The Rakyat Post. AI can make mistakes, so check the original for details.